0001140361-13-009688.txt : 20130227
0001140361-13-009688.hdr.sgml : 20130227
20130227194800
ACCESSION NUMBER: 0001140361-13-009688
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130226
FILED AS OF DATE: 20130227
DATE AS OF CHANGE: 20130227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JORDEN DAVID EMERSON
CENTRAL INDEX KEY: 0001313516
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33004
FILM NUMBER: 13648699
MAIL ADDRESS:
STREET 1: 2635 TECHNOLOGY FOREST BLVD.
CITY: THE WOODLANDS
STATE: TX
ZIP: 77381
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Opexa Therapeutics, Inc.
CENTRAL INDEX KEY: 0001069308
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 760333165
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2635 TECHNOLOGY FOREST BLVD.
CITY: THE WOODLANDS
STATE: TX
ZIP: 77381
BUSINESS PHONE: (281) 272-9331
MAIL ADDRESS:
STREET 1: 2635 TECHNOLOGY FOREST BLVD.
CITY: THE WOODLANDS
STATE: TX
ZIP: 77381
FORMER COMPANY:
FORMER CONFORMED NAME: PharmaFrontiers Corp.
DATE OF NAME CHANGE: 20051011
FORMER COMPANY:
FORMER CONFORMED NAME: PHARMAFRONTIERS CORP
DATE OF NAME CHANGE: 20040816
FORMER COMPANY:
FORMER CONFORMED NAME: SPORTAN UNITED INDUSTRIES INC
DATE OF NAME CHANGE: 19990305
4
1
doc1.xml
FORM 4
X0306
4
2013-02-26
0
0001069308
Opexa Therapeutics, Inc.
OPXA
0001313516
JORDEN DAVID EMERSON
C/O OPEXA THERAPEUTICS, INC.
2635 TECHNOLOGY FOREST BLVD.
THE WOODLANDS
TX
77381
1
1
0
0
Acting Chief Financial Officer
Convertible Promissory Note
1.30
2013-02-26
4
D
0
100000
A
2013-01-23
2014-01-23
Common Stock
77034
0
D
The Issuer repaid the outstanding balance of the Note in cash on 2-26-13 and the Note was cancelled.
/s/ David E. Jorden
2013-02-27